Evidence map›Paper›PMID 30477588›Full record

ArticleBMC research notes2018

Temporal trend of the proportion of patients presenting with advanced HIV in French Guiana: stuck on the asymptote?

Mathieu Nacher, Florence Huber, Leila Adriouch, Félix Djossou, Antoine Adenis, Pierre Couppié

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mathieu NacherCentre d'Investigation Clinique, CIC Inserm 1424, Cayenne Hospital, rue des Flamboyant, BP 6006, 97306, Cayenne Cedex, French Guiana. mathieu.nacher66@gmail.com.ORCID http://orcid.org/0000-0001-9397-3204
Florence HuberCOREVIH Guyane, Cayenne Hospital, rue des Flamboyant, BP 6006, 97306, Cayenne Cedex, French Guiana.
Leila AdriouchCOREVIH Guyane, Cayenne Hospital, rue des Flamboyant, BP 6006, 97306, Cayenne Cedex, French Guiana.
Félix DjossouService des Maladies Infectieuses et Tropicales, Cayenne Hospital, rue des Flamboyant, BP 6006, 97306, Cayenne Cedex, French Guiana.
Antoine AdenisCentre d'Investigation Clinique, CIC Inserm 1424, Cayenne Hospital, rue des Flamboyant, BP 6006, 97306, Cayenne Cedex, French Guiana.
Pierre CouppiéService de Dermatologie, Cayenne Hospital, rue des Flamboyant, BP 6006, 97306, Cayenne Cedex, French Guiana.
University of French Guiana · GF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn French Guiana, the French territory with the most preoccupying HIV epidemic, there have been great efforts to intensify and diversify HIV testing strategies. The aim of the present study was to review the temporal trends of patients diagnosed with advanced HIV disease in French Guiana. Data trends from the HIV cohort of French Guiana between 1996 and 2016 were thus analyzed.

resultsThe proportion of patients diagnosed with advanced disease did not decline over time. Males had lower CD4 counts at the time of diagnosis and there was a plateau for both males (around 40%) and females (around 25%) with no apparent reduction of the proportion of advanced disease. Older age groups and migrants presented more often with advanced disease. By contrast, the proportion of patients diagnosed with stage B and C disease declined over time and the CD4 count at antiretroviral initiation and the CD4 nadir increased over time. Despite some progress, the group of patients with advanced disease reached a plateau around 30% suggesting this particular group still has epidemiological importance in driving the epidemic and in fueling morbidity and mortality, and thus remains a challenge for testing strategies.

Indexed as

AdolescentAdultAnti-Retroviral AgentsCD4 Lymphocyte CountCD4-Positive T-LymphocytesCommunicable Disease ControlDisease ProgressionEmigrants and ImmigrantsEpidemicsFemaleFrench GuianaHIV InfectionsHumansMaleMiddle AgedTime FactorsAnti-Retroviral AgentsAdvanced diseaseAIDSCD4French GuianaHIV

Identifiers

PMID30477588
PMCPMC6258272
OpenAlexW2902598781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.